<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:webfeeds="http://webfeeds.org/rss/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>eLife: latest articles by subject</title>
    <link>https://elifesciences.org</link>
    <description>Articles published by eLife, filtered by given subjects</description>
    <atom:link href="https://observer.elifesciences.org/report/latest-articles-by-subject" rel="self"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>observer (using python-feedgen)</generator>
    <language>en</language>
    <lastBuildDate>Sun, 15 Mar 2026 01:54:27 +0000</lastBuildDate>
    <webfeeds:analytics id="G-TZ0BM7CV5E" engine="GoogleAnalytics"/>
    <item>
      <title>Sperm motility in mice with oligo-astheno-teratozoospermia restored by in vivo injection and electroporation of naked mRNA</title>
      <link>https://elifesciences.org/articles/94514</link>
      <description>Oligo-astheno-teratozoospermia (OAT), a recurrent cause of male infertility, is the most frequent disorder of spermatogenesis with a predominantly genetic origin. Patients and mice bearing mutations in the &lt;i&gt;ARMC2&lt;/i&gt; gene exhibit reduced sperm concentration, multiple morphological defects, and impaired motility, defining a canonical OAT phenotype. Intracytoplasmic sperm injection (ICSI) is required to treat this condition; however, it is associated with a slightly increased risk of birth defects compared with natural conception, highlighting the need for novel targeted therapies. Here, in vivo testicular injection followed by electroporation of capped, polyadenylated naked messenger RNA (mRNA) was evaluated as a strategy to treat &lt;i&gt;ARMC2&lt;/i&gt;-related infertility in mice. mRNAs encoding reporter proteins were used to assess expression efficiency and kinetics using in vivo and in vitro 2D and 3D imaging. Reporter proteins were detected in germ cells for up to three weeks, demonstrating the feasibility of mRNA-based approaches. These results were compared with a non-integrative plasmid Enhanced Episomal Vector, which induced weak and transient expression in spermatogenic cells. Delivery of &lt;i&gt;Armc2&lt;/i&gt; mRNA restored morphologically normal and motile sperm in deficient males, capable of producing embryos via in vitro fertilization and ICSI. These findings provide proof-of-concept that mRNA electroporation can restore sperm motility and fertilizing potential, offering a novel strategy to correct monogenic male infertility.</description>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Altan Yavuz)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Bernard Verrier)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Camille Ayad)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Célia Tebbakh)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Charles Coutton)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Charline Vilpreux)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Christophe Arnoult)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Corinne Loeuillet)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Edgar Del Llano)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Elsa Giordani)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Emeline Lambert)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Florence Appaix)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Geneviève Chevalier)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Guillaume Martinez)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Jacques Brocard)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Jean Luc Duteyrat)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Jessica Escoffier)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Julien Vollaire)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Lisa De Macedo)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Magali Court)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Maxime Henry)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Paul Fourquin)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Pierre F Ray)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Sekou Ahmed Conté)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Sofia Andrade Rebelo)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Veronique Josserand)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Zeina Wehbe)</author>
      <author>jessica.escoffier@univ-grenoble-alpes.fr (Zine Eddine Kherraf)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.94514</guid>
      <category>Medicine</category>
      <pubDate>Tue, 03 Mar 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-03-03T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Single transcript level atlas of oxytocin and the oxytocin receptor in the mouse brain</title>
      <link>https://elifesciences.org/articles/95215</link>
      <description>Oxytocin (OXT), a primitive nonapeptide known to regulate reproduction and social behaviors, is synthesized primarily in the hypothalamus and is secreted &lt;i&gt;via&lt;/i&gt; hypophyseal-portal system of the posterior pituitary gland. In line with the premise that pituitary hormones, traditionally thought of as regulators of single targets, display an array of central and peripheral actions, we found that OXT directly affects bone and body composition. The effect of OXT on bone remodeling are physiologically relevant, as elevated OXT levels during pregnancy and lactation cause calcium mobilization from the maternal skeleton for intergenerational calcium transfer towards fetal bone mineralization. There is an equally large body of evidence that has established the presence of OXT receptors (OXTRs) in the brain through which central functions, such as social bonding, and peripheral functions, such as the regulation of body composition, are exerted. To purposefully address effects of OXT on the brain, we used RNAscope to map OXT and OXTR expression, at the single transcript level, in the whole female and male mouse brains. Identification of brain nuclei with the highest OXT and OXTR transcript density sheds further light on functional OXT nodes that could be further interrogated experimentally to define new physiologic circuitry.</description>
      <author>vitaly.ryu@mssm.edu (Anisa Azatovna Gumerova)</author>
      <author>vitaly.ryu@mssm.edu (Daria Lizneva)</author>
      <author>vitaly.ryu@mssm.edu (Emily Weiss)</author>
      <author>vitaly.ryu@mssm.edu (Farhath Sultana)</author>
      <author>vitaly.ryu@mssm.edu (Funda Korkmaz)</author>
      <author>vitaly.ryu@mssm.edu (Georgii Pevnev)</author>
      <author>vitaly.ryu@mssm.edu (Hasni Kannangara)</author>
      <author>vitaly.ryu@mssm.edu (Jay J Cao)</author>
      <author>vitaly.ryu@mssm.edu (Ki A Goosens)</author>
      <author>vitaly.ryu@mssm.edu (Liam Cullen)</author>
      <author>vitaly.ryu@mssm.edu (Mone Zaidi)</author>
      <author>vitaly.ryu@mssm.edu (Ofer Moldavski)</author>
      <author>vitaly.ryu@mssm.edu (Orly Barak)</author>
      <author>vitaly.ryu@mssm.edu (Ronit Witztum)</author>
      <author>vitaly.ryu@mssm.edu (Steven Lee Sims)</author>
      <author>vitaly.ryu@mssm.edu (Tal Frolinger)</author>
      <author>vitaly.ryu@mssm.edu (Tony Yuen)</author>
      <author>vitaly.ryu@mssm.edu (Vitaly Ryu)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.95215</guid>
      <category>Medicine</category>
      <pubDate>Mon, 23 Feb 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-02-23T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Gender differences in submission behavior exacerbate publication disparities in elite journals</title>
      <link>https://elifesciences.org/articles/90049</link>
      <description>Women are particularly underrepresented as leading authors of papers in journals of the highest impact factor, with substantial consequences for their careers. While a large body of research has focused on the outcome and the process of peer review, fewer articles have explicitly focused on gendered submission behavior and the explanations for these differences. In our study of nearly 5000 active authors, we find that women are less likely to report having submitted papers to journals of the highest impact (e.g., &lt;i&gt;Science&lt;/i&gt;, &lt;i&gt;Nature&lt;/i&gt;, or &lt;i&gt;PNAS&lt;/i&gt;) and to submit fewer manuscripts, on average, than men when they do submit. Women were more likely to indicate that they did not submit their papers (in general and their subsequently most cited papers) to high-impact journals because they were advised not to. In the aggregate, no statistically significant difference was observed between men and women in how they rated the quality of their work. Nevertheless, regardless of discipline, women were more likely than men to indicate that their ‘&lt;i&gt;work was not ground-breaking or sufficiently novel&lt;/i&gt;’ as a rationale for not submitting to one of the listed prestigious journals. Men were more likely than women to indicate that the ‘&lt;i&gt;work would fit better in a more specialized journal&lt;/i&gt;’&lt;i&gt;.&lt;/i&gt; We discuss the implications of these findings and interventions that can serve to mitigate the disparities caused by gendered differences in submission behavior.</description>
      <author>vincent.lariviere@umontreal.ca (Cassidy R Sugimoto)</author>
      <author>vincent.lariviere@umontreal.ca (Chaoqun Ni)</author>
      <author>vincent.lariviere@umontreal.ca (Giovanna Badia)</author>
      <author>vincent.lariviere@umontreal.ca (Isabel Basson)</author>
      <author>vincent.lariviere@umontreal.ca (Nathalie Tufenkji)</author>
      <author>vincent.lariviere@umontreal.ca (Vincent Larivière)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.90049</guid>
      <category>Medicine</category>
      <pubDate>Fri, 20 Feb 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-02-20T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>MRI sets its sights on collagen</title>
      <link>https://elifesciences.org/articles/110375</link>
      <description>Reducing the echo time of a whole-body MRI scanner makes it possible to image collagen, an important structural protein found in bones and tendons.</description>
      <author>fritz.schick@med.uni-tuebingen.de (Fritz Schick)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.110375</guid>
      <category>Medicine</category>
      <category>Structural Biology and Molecular Biophysics</category>
      <pubDate>Mon, 02 Feb 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-02-02T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>A titin missense variant drives atrial electrical remodeling and is associated with atrial fibrillation</title>
      <link>https://elifesciences.org/articles/104719</link>
      <description>Rare and common genetic variants contribute to the risk of atrial fibrillation (AF). Although ion channels were among the first AF candidate genes identified, rare loss-of-function variants in structural genes, such as &lt;i&gt;TTN&lt;/i&gt;, have also been implicated in AF pathogenesis, partly through the development of atrial myopathy; however, the underlying mechanisms are poorly understood. While &lt;i&gt;TTN&lt;/i&gt; truncating variants (&lt;i&gt;TTN&lt;/i&gt;tvs) have been causally linked to arrhythmia and cardiomyopathy syndromes, the role of missense variants (mvs) remains unclear. We show that rare &lt;i&gt;TTNmvs&lt;/i&gt; are associated with worse clinical outcomes in a single-center ethnic minority clinical cohort and uncover a pathogenic mechanism by which the T32756I variant drives AF. Modeling the &lt;i&gt;TTN&lt;/i&gt;-T32756I variant using human induced pluripotent stem cell-derived atrial cardiomyocytes (iPSC-aCMs) revealed that the mutant cells display aberrant contractility, increased activity of a cardiac potassium channel (KCNQ1, Kv7.1), and dysregulated calcium homeostasis without compromising the sarcomeric integrity of the atrial cardiomyocytes. We also show that a titin-binding protein, the Four-and-a-Half Lim domains 2 (FHL2), has increased binding with KCNQ1 and its modulatory subunit KCNE1 in the &lt;i&gt;TTN-&lt;/i&gt;T32756I-iPSC-aCMs, enhancing the slow delayed rectifier potassium current (&lt;i&gt;I&lt;/i&gt;&lt;sub&gt;ks&lt;/sub&gt;). Suppression of FHL2 in mutant iPSC-aCMs normalized the &lt;i&gt;I&lt;/i&gt;&lt;sub&gt;ks&lt;/sub&gt;, supporting FHL2 as an &lt;i&gt;I&lt;/i&gt;&lt;sub&gt;ks&lt;/sub&gt; modulator. Our findings demonstrate that a single amino acid substitution in titin not only impairs its function but also remodels ion channels, contributing to AF. These findings underscore the importance of high-throughput screening to assess the pathogenicity of &lt;i&gt;TTN&lt;/i&gt;mvs and establish a mechanistic connection between titin, potassium ion channels, and sarcomeric proteins, which may represent a novel therapeutic target.</description>
      <author>gmmahmud@uic.edu (Abhinaya Baskaran)</author>
      <author>gmmahmud@uic.edu (Arvind Sridhar)</author>
      <author>gmmahmud@uic.edu (Asia Owais)</author>
      <author>gmmahmud@uic.edu (Aylin Ornelas Loredo)</author>
      <author>gmmahmud@uic.edu (Bahaa Al-Azzam)</author>
      <author>gmmahmud@uic.edu (Brandon Chalazan)</author>
      <author>gmmahmud@uic.edu (Dawood Darbar)</author>
      <author>gmmahmud@uic.edu (Faisal A Darbar)</author>
      <author>gmmahmud@uic.edu (Hanna Chen)</author>
      <author>gmmahmud@uic.edu (Jaime DeSantiago)</author>
      <author>gmmahmud@uic.edu (Jalees Rehman)</author>
      <author>gmmahmud@uic.edu (Mahmud Arif Pavel)</author>
      <author>gmmahmud@uic.edu (Michael Hill)</author>
      <author>gmmahmud@uic.edu (Miles Barney)</author>
      <author>gmmahmud@uic.edu (Shashank Sandu)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104719</guid>
      <category>Medicine</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Thu, 22 Jan 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-01-22T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Association between continuous glucose monitoring-derived metrics and coronary plaque vulnerability: A retrospective exploratory analysis</title>
      <link>https://elifesciences.org/articles/102860</link>
      <author>ogawa@med.kobe-u.ac.jp (Hikaru Sugimoto)</author>
      <author>ogawa@med.kobe-u.ac.jp (Hiromasa Otake)</author>
      <author>ogawa@med.kobe-u.ac.jp (Kazuhiko Sakaguchi)</author>
      <author>ogawa@med.kobe-u.ac.jp (Ken-Ichi Hirata)</author>
      <author>ogawa@med.kobe-u.ac.jp (Ken-ichi Hironaka)</author>
      <author>ogawa@med.kobe-u.ac.jp (Natsu Otowa-Suematsu)</author>
      <author>ogawa@med.kobe-u.ac.jp (Shinya Kuroda)</author>
      <author>ogawa@med.kobe-u.ac.jp (Tomoko Yamada)</author>
      <author>ogawa@med.kobe-u.ac.jp (Wataru Ogawa)</author>
      <author>ogawa@med.kobe-u.ac.jp (Yushi Hirota)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.102860</guid>
      <category>Medicine</category>
      <pubDate>Thu, 15 Jan 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-01-15T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Dual-modal metabolic analysis reveals hypothermia-reversible uncoupling of oxidative phosphorylation in neonatal brain hypoxia-ischemia</title>
      <link>https://elifesciences.org/articles/100129</link>
      <description>Hypoxia-ischemia (HI), which disrupts the oxygen supply-demand balance in the brain by impairing blood oxygen supply and the cerebral metabolic rate of oxygen (CMRO&lt;sub&gt;2&lt;/sub&gt;), is a leading cause of neonatal brain injury. However, it is unclear how post-HI hypothermia helps to restore the balance, as cooling reduces CMRO&lt;sub&gt;2&lt;/sub&gt;. Also, how transient HI leads to secondary energy failure (SEF) in neonatal brains remains elusive. Using photoacoustic microscopy, we examined the effects of HI on CMRO&lt;sub&gt;2&lt;/sub&gt; in awake 10-day-old mice, supplemented by bioenergetic analysis of purified cortical mitochondria. Our results show that while HI suppresses ipsilateral CMRO&lt;sub&gt;2&lt;/sub&gt;, it sparks a prolonged CMRO&lt;sub&gt;2&lt;/sub&gt;-surge post-HI, associated with increased mitochondrial oxygen consumption, superoxide emission, and reduced mitochondrial membrane potential necessary for ATP synthesis—indicating oxidative phosphorylation (OXPHOS) uncoupling. Post-HI hypothermia prevents the CMRO&lt;sub&gt;2&lt;/sub&gt;-surge by constraining oxygen extraction fraction, reduces mitochondrial oxidative stress, and maintains ATP and N-acetylaspartate levels, resulting in attenuated infarction at 24 hr post-HI. Our findings suggest that OXPHOS-uncoupling induced by the post-HI CMRO&lt;sub&gt;2&lt;/sub&gt;-surge underlies SEF and blocking the surge is a key mechanism of hypothermia protection. Also, our study highlights the potential of optical CMRO&lt;sub&gt;2&lt;/sub&gt; measurements for detecting neonatal HI brain injury and guiding the titration of therapeutic hypothermia at the bedside.</description>
      <author>ck6cb@virginia.edu (Chia-Yi Kuan)</author>
      <author>ck6cb@virginia.edu (Diana M Lindquist)</author>
      <author>ck6cb@virginia.edu (Elizabeth Fugate)</author>
      <author>ck6cb@virginia.edu (Ellen P Grant)</author>
      <author>ck6cb@virginia.edu (Hong-Ru Chen)</author>
      <author>ck6cb@virginia.edu (Marchelle R Smucker)</author>
      <author>ck6cb@virginia.edu (Naidi Sun)</author>
      <author>ck6cb@virginia.edu (Rui Cao)</author>
      <author>ck6cb@virginia.edu (Song Hu)</author>
      <author>ck6cb@virginia.edu (Yiming Wang)</author>
      <author>ck6cb@virginia.edu (Yi-Min Kuo)</author>
      <author>ck6cb@virginia.edu (Yu-Yo Sun)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.100129</guid>
      <category>Medicine</category>
      <category>Neuroscience</category>
      <pubDate>Mon, 29 Dec 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-12-29T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>GPR30 in spinal cholecystokinin-positive neurons modulates neuropathic pain</title>
      <link>https://elifesciences.org/articles/102874</link>
      <description>Neuropathic pain, a major health problem affecting 7–10% of the global population, lacks effective treatment due to its elusive mechanisms. Cholecystokinin-positive (CCK&lt;sup&gt;+&lt;/sup&gt;) neurons in the spinal dorsal horn (SDH) are critical for neuropathic pain, yet the underlying molecular mechanisms remain unclear. Here, we show that the membrane estrogen receptor G-protein coupled estrogen receptor (GPER/GPR30) in spinal neurons was significantly upregulated in chronic constriction injury (CCI) mice and that inhibition of GPR30 in CCK&lt;sup&gt;+&lt;/sup&gt; neurons reversed CCI-induced neuropathic pain. Furthermore, GPR30 in spinal CCK&lt;sup&gt;+&lt;/sup&gt; neurons was essential for the enhancement of AMPA-mediated excitatory synaptic transmission in CCI mice. Moreover, GPR30 was expressed in spinal CCK&lt;sup&gt;+&lt;/sup&gt; neurons that received direct projection from the primary sensory cortex (S1-SDH). Chemogenetic inhibition of S1-SDH post-synaptic neurons alleviated CCI-induced neuropathic pain. Conversely, chemogenetic activation of these neurons mimicked neuropathic pain symptoms, which were attenuated by spinal inhibition of GPR30. Finally, we confirmed that GPR30 in S1-SDH post-synaptic neurons was required for CCI-induced neuropathic pain. Taken together, our findings suggest that GPR30 in spinal CCK&lt;sup&gt;+&lt;/sup&gt; neurons and S1-SDH post-synaptic neurons is pivotal for neuropathic pain, thereby representing a promising therapeutic target for neuropathic pain.</description>
      <author>xuzz@zju.edu.cn (Ange Dai)</author>
      <author>xuzz@zju.edu.cn (Cuicui Jiao)</author>
      <author>xuzz@zju.edu.cn (Fangfang Zhu)</author>
      <author>xuzz@zju.edu.cn (Fang Xu)</author>
      <author>xuzz@zju.edu.cn (HongHai Zhang)</author>
      <author>xuzz@zju.edu.cn (Hua Li)</author>
      <author>xuzz@zju.edu.cn (Hui Wu)</author>
      <author>xuzz@zju.edu.cn (Jiaqian Xie)</author>
      <author>xuzz@zju.edu.cn (Lihong Sun)</author>
      <author>xuzz@zju.edu.cn (Linghua Xie)</author>
      <author>xuzz@zju.edu.cn (Luyang Wang)</author>
      <author>xuzz@zju.edu.cn (Qing Chen)</author>
      <author>xuzz@zju.edu.cn (Qi Xu)</author>
      <author>xuzz@zju.edu.cn (Shulan Xie)</author>
      <author>xuzz@zju.edu.cn (Wenxin Zhang)</author>
      <author>xuzz@zju.edu.cn (Xinzhong Chen)</author>
      <author>xuzz@zju.edu.cn (Xuelong Zhou)</author>
      <author>xuzz@zju.edu.cn (Yue Yang)</author>
      <author>xuzz@zju.edu.cn (Zhen-Zhong Xu)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.102874</guid>
      <category>Medicine</category>
      <category>Neuroscience</category>
      <pubDate>Tue, 23 Dec 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-12-23T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Are peer reviewers influenced by their work being cited?</title>
      <link>https://elifesciences.org/articles/108748</link>
      <description>Peer reviewers sometimes comment that their own journal articles should be cited by the journal article under review. Comments concerning relevant articles can be justified, but comments can also be unrelated coercive citations. Here, we used a matched observational study design to explore how citations influence the peer review process. We used a sample of more than 37,000 peer reviews from four journals that use open peer review and make all article versions available. We find that reviewers who were cited in versions after version 1 were more likely to make a favourable recommendation (odds ratio = 1.61; adjusted 99.4% CI: 1.16–2.23), whereas being cited in the first version did not improve their recommendation (odds ratio = 0.84; adjusted 99.4% CI: 0.69–1.03). For all versions of the articles, the reviewers who commented that their own articles should be cited were less likely to recommend approval compared to the reviewers who did not, with the strongest association after the first version (odds ratio = 0.15; adjusted 99.4% CI: 0.08–0.30). Reviewers who included a citation to their own articles were much more likely to approve a revised article that cited their articles compared to a revised article that did not (odds ratio = 3.5; 95% CI: 2.0–6.1). Some reviewers’ recommendations depend on whether they are cited or want to be cited. Reviewer citation requests can turn peer review into a transaction rather than an objective critique of the article.</description>
      <author>a.barnett@qut.edu.au (Adrian Barnett)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.108748</guid>
      <category>Medicine</category>
      <pubDate>Tue, 23 Dec 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-12-23T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Addressing cultural and knowledge barriers to enable preclinical sex inclusive research</title>
      <link>https://elifesciences.org/articles/106545</link>
      <description>For over 30 years, research has highlighted a sex bias in early research, risking the validity of biological knowledge. The first step towards change is effectively challenging misconceptions, allowing researchers to perceive sex inclusive research as doable. Utilising the theory of planned behaviour, we quantified researchers’ intention as a proxy measure for conducting sex inclusive research and explored attitude (value of the behaviour), subjective norm (perceived social pressure), and behavioural control (ability to conduct the behaviour). Additionally, we quantified the knowledge gap, prevalence of misconceptions, and assessed perceived benefits and barriers. We tested a workshop intervention that directly challenges the cultural embedded barriers. The data shows researchers’ intentions were high, but they had weak statistical knowledge and misunderstandings leading to a perception that inclusive research is prohibitive due to cost and animal use. We demonstrate that participation in the training intervention improved knowledge, altered the perceived barriers, and cultural expectations.</description>
      <author>Natasha.Karp@astrazeneca.com (Amrita Ahluwalia)</author>
      <author>Natasha.Karp@astrazeneca.com (Andrew Rooney)</author>
      <author>Natasha.Karp@astrazeneca.com (Benjamin Phillips)</author>
      <author>Natasha.Karp@astrazeneca.com (Brianna N Gaskill)</author>
      <author>Natasha.Karp@astrazeneca.com (Holly Rafferty)</author>
      <author>Natasha.Karp@astrazeneca.com (Jonathan Ho)</author>
      <author>Natasha.Karp@astrazeneca.com (Natasha A Karp)</author>
      <author>Natasha.Karp@astrazeneca.com (Oladele Olajide Onada)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.106545</guid>
      <category>Medicine</category>
      <pubDate>Wed, 10 Dec 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-12-10T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>The denitrosylase SCoR2 controls cardioprotective metabolic reprogramming</title>
      <link>https://elifesciences.org/articles/106601</link>
      <description>Acute myocardial infarction (MI) is a leading cause of morbidity and mortality, and therapeutic options remain limited. Endogenously generated nitric oxide (NO) is highly cardioprotective, but protection is not replicated by nitroso-vasodilators (e.g., nitrates, nitroprusside) used in clinical practice, highlighting specificity in NO-based signaling and untapped therapeutic potential. Signaling by NO is mediated largely by &lt;i&gt;S&lt;/i&gt;-nitrosylation, entailing specific enzymes that form and degrade &lt;i&gt;S&lt;/i&gt;-nitrosothiols in proteins (SNO-proteins), termed nitrosylases and denitrosylases, respectively. SNO-CoA Reductase 2 (SCoR2; product of the &lt;i&gt;Akr1a1&lt;/i&gt; gene) is a recently discovered protein denitrosylase. Genetic variants in SCoR2 have been associated with cardiovascular disease, but its function is unknown. Here, we show that mice lacking SCoR2/AKR1A1 exhibit robust protection in an animal model of MI. SCoR2 regulates ketolytic energy availability, antioxidant levels, and polyol homeostasis via &lt;i&gt;S&lt;/i&gt;-nitrosylation of key metabolic effectors. Human cardiomyopathy shows reduced SCoR2 expression and an &lt;i&gt;S&lt;/i&gt;-nitrosylation signature of metabolic reprogramming, mirroring SCoR2&lt;sup&gt;−/−&lt;/sup&gt; mice. Deletion of SCoR2 thus coordinately reprograms multiple metabolic pathways—ketone body utilization, glycolysis, pentose phosphate shunt, and polyol metabolism—to limit infarct size, establishing SCoR2 as a novel regulator in the injured myocardium and a potential drug target.</description>
      <author>jss156@case.edu (Dawson Miller)</author>
      <author>jss156@case.edu (Hua-Lin Zhou)</author>
      <author>jss156@case.edu (Jonathan S Stamler)</author>
      <author>jss156@case.edu (Justin Lin)</author>
      <author>jss156@case.edu (Qiuying Chen)</author>
      <author>jss156@case.edu (Richard T Premont)</author>
      <author>jss156@case.edu (Riti Kalra)</author>
      <author>jss156@case.edu (Rongli Zhang)</author>
      <author>jss156@case.edu (Steven S Gross)</author>
      <author>jss156@case.edu (Walter J Koch)</author>
      <author>jss156@case.edu (Zachary W Grimmett)</author>
      <author>jss156@case.edu (Zhaoxia Qian)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.106601</guid>
      <category>Medicine</category>
      <pubDate>Mon, 17 Nov 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-11-17T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Cell-autonomous and non-cell-autonomous effects of Arginase 2 on cardiac aging</title>
      <link>https://elifesciences.org/articles/94794</link>
      <description>Aging is a predominant risk factor for heart disease. Aging heart reveals low-grade chronic inflammation, cell apoptosis, cardiac fibrosis, and increased vulnerability to ischemic injury. The underlying molecular mechanisms responsible for cardiac aging and its susceptibility to injury are not fully understood. Although literature reports a role for mitochondrial Arginase 2 (ARG2) in heart failure, contradictory results are reported. How ARG2 participates in cardiac aging is still unknown. In this study, we demonstrate that &lt;i&gt;Arg2&lt;/i&gt; is not expressed in cardiomyocytes from aged mice and humans but is upregulated in non-myocyte cells, including macrophages, fibroblasts, and endothelial cells. Mice with genetic deficiency of &lt;i&gt;Arg2&lt;/i&gt; (&lt;i&gt;Arg2&lt;sup&gt;-/-&lt;/sup&gt;&lt;/i&gt;) are protected from age-associated cardiac inflammation, myocyte apoptosis, interstitial and perivascular fibrosis, endothelial-mesenchymal transition (EndMT), and susceptibility to ischemic injury. Further experiments show that ARG2 mediates IL-1β release from macrophages of old mice, contributing to the cardiac aging phenotype. In addition, ARG2 enhances mitochondrial reactive oxygen species (mtROS) and activates cardiac fibroblasts that is inhibited by inhibition of mtROS. Thus, our study demonstrates a non-cell-autonomous effect of ARG2 on cardiomyocytes, fibroblasts, and endothelial cells mediated by IL-1β from aging macrophages as well as a cell-autonomous effect of ARG2 through mtROS in fibroblasts contributing to cardiac aging phenotype.</description>
      <author>duilio.potenza@unifr.ch (Andrea Brenna)</author>
      <author>duilio.potenza@unifr.ch (Aurelien Frobert)</author>
      <author>duilio.potenza@unifr.ch (Duilio M Potenza)</author>
      <author>duilio.potenza@unifr.ch (Guillaume Ajalbert)</author>
      <author>duilio.potenza@unifr.ch (Kirsten D Mertz)</author>
      <author>duilio.potenza@unifr.ch (Marie-Noelle Giraud)</author>
      <author>duilio.potenza@unifr.ch (Stephane Cook)</author>
      <author>duilio.potenza@unifr.ch (Xin Cheng)</author>
      <author>duilio.potenza@unifr.ch (Xiu-Fen Ming)</author>
      <author>duilio.potenza@unifr.ch (Zhihong Yang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.94794</guid>
      <category>Medicine</category>
      <pubDate>Tue, 04 Nov 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-11-04T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Critique of impure reason: Unveiling the reasoning behaviour of medical large language models</title>
      <link>https://elifesciences.org/articles/106187</link>
      <description>Despite the current ubiquity of large language models (LLMs) across the medical domain, there is a surprising lack of studies which address their &lt;i&gt;reasoning behaviour&lt;/i&gt;. We emphasise the importance of understanding &lt;i&gt;reasoning behaviour&lt;/i&gt; as opposed to high-level prediction accuracies, since it is equivalent to explainable AI (XAI) in this context. In particular, achieving XAI in medical LLMs used in the clinical domain will have a significant impact across the healthcare sector. Therefore, in this work, we adapt the existing concept of &lt;i&gt;reasoning behaviour&lt;/i&gt; and articulate its interpretation within the specific context of medical LLMs. We survey and categorise current state-of-the-art approaches for modelling and evaluating &lt;i&gt;reasoning&lt;/i&gt; in medical LLMs. Additionally, we propose theoretical frameworks which can empower medical professionals or machine learning engineers to gain insight into the low-level reasoning operations of these previously obscure models. We also outline key open challenges facing the development of &lt;i&gt;large reasoning models&lt;/i&gt;. The subsequent increased transparency and trust in medical machine learning models by clinicians as well as patients will accelerate the integration, application as well as further development of medical AI for the healthcare system as a whole.</description>
      <author>shamus@qmed.asia (Shamus Zi Yang Sim)</author>
      <author>shamus@qmed.asia (Tyrone Chen)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.106187</guid>
      <category>Computational and Systems Biology</category>
      <category>Medicine</category>
      <pubDate>Tue, 28 Oct 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-10-28T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Monitoring circulating cell-free HPV DNA in metastatic or recurrent cervical cancer: clinical significance and treatment implications</title>
      <link>https://elifesciences.org/articles/101887</link>
      <author>juejue3149@163.com (Hanmei Lou)</author>
      <author>juejue3149@163.com (Juan Ni)</author>
      <author>juejue3149@163.com (Maowei Ni)</author>
      <author>juejue3149@163.com (Qing Xu)</author>
      <author>juejue3149@163.com (Tao Feng)</author>
      <author>juejue3149@163.com (Wumin Dai)</author>
      <author>juejue3149@163.com (Zhuomin Yin)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.101887</guid>
      <category>Cancer Biology</category>
      <category>Medicine</category>
      <pubDate>Wed, 17 Sep 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-09-17T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Correction: Association of human breast cancer CD44&lt;sup&gt;-&lt;/sup&gt;/CD24&lt;sup&gt;-&lt;/sup&gt; cells with delayed distant metastasis</title>
      <link>https://elifesciences.org/articles/109109</link>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.109109</guid>
      <category>Cancer Biology</category>
      <category>Medicine</category>
      <pubDate>Wed, 10 Sep 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-09-10T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Heterozygous variants in &lt;i&gt;PLCG1&lt;/i&gt; affect hearing, vision, cardiac, and immune function</title>
      <link>https://elifesciences.org/articles/95887</link>
      <description>Phospholipase C isozymes (PLCs) hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP&lt;sub&gt;2&lt;/sub&gt;) into inositol 1,4,5-trisphosphate (IP&lt;sub&gt;3&lt;/sub&gt;) and diacylglycerol (DAG), important signaling molecules involved in many cellular processes including Ca&lt;sup&gt;2+&lt;/sup&gt; release from the endoplasmic reticulum (ER). &lt;i&gt;PLCG1&lt;/i&gt; encodes the PLCγ1 isozyme that is broadly expressed. Hyperactive somatic mutations of &lt;i&gt;PLCG1&lt;/i&gt; are observed in multiple cancers, but only one germline variant has been reported. Here, we describe seven individuals with heterozygous missense variants in &lt;i&gt;PLCG1&lt;/i&gt; [p.(Asp1019Gly), p.(His380Arg), p.(Asp1165Gly), and p.(Leu597Phe)] who present with hearing impairment (5/7), ocular pathology (4/7), cardiac septal defects (3/6), and various immunological issues (5/7). To model these variants &lt;i&gt;in vivo&lt;/i&gt;, we generated the analogous variants in the Drosophila ortholog, &lt;i&gt;small wing&lt;/i&gt; (&lt;i&gt;sl&lt;/i&gt;). We created a null allele &lt;i&gt;sl&lt;sup&gt;T2A&lt;/sup&gt;&lt;/i&gt; and assessed its expression pattern. &lt;i&gt;sl&lt;/i&gt; is broadly expressed, including wing discs, eye discs, and a subset of neurons and glia. &lt;i&gt;sl&lt;sup&gt;T2A&lt;/sup&gt;&lt;/i&gt; mutant flies exhibit wing size reductions, ectopic wing veins, and supernumerary photoreceptors. We document that mutant flies also exhibit a reduced lifespan and age-dependent locomotor defects. Expressing wild-type &lt;i&gt;sl&lt;/i&gt; in &lt;i&gt;sl&lt;sup&gt;T2A&lt;/sup&gt;&lt;/i&gt; mutant flies rescues the loss-of-function phenotypes, whereas the variants increase lethality. Ectopic expression of an established hyperactive &lt;i&gt;PLCG1&lt;/i&gt; variant, p.(Asp1165His) in the wing pouch causes elevated Ca&lt;sup&gt;2+&lt;/sup&gt; activity and severe wing phenotypes. These phenotypes are also observed when the p.(Asp1019Gly) or p.(Asp1165Gly) variants are overexpressed in the wing pouch, arguing that these are gain-of-function variants. However, the wing phenotypes associated with p.(His380Arg) or p.(Leu597Phe) overexpression are either mild or only partially penetrant. Our data suggest that the heterozygous missense variants reported here affect protein function differentially and contribute to the clinical features observed in the affected individuals.</description>
      <author>hbellen@bcm.edu (Aimee Allworth)</author>
      <author>hbellen@bcm.edu (Barbara Mandriani)</author>
      <author>hbellen@bcm.edu (Catherine E Otten)</author>
      <author>hbellen@bcm.edu (David Li-Kroeger)</author>
      <author>hbellen@bcm.edu (Debdeep Dutta)</author>
      <author>hbellen@bcm.edu (Elizabeth Blue)</author>
      <author>hbellen@bcm.edu (Giuseppe Merla)</author>
      <author>hbellen@bcm.edu (Hugo J Bellen)</author>
      <author>hbellen@bcm.edu (Ian A Glass)</author>
      <author>hbellen@bcm.edu (Jeremie Rosain)</author>
      <author>hbellen@bcm.edu (Jill A Rosenfeld)</author>
      <author>hbellen@bcm.edu (Jingheng Chen)</author>
      <author>hbellen@bcm.edu (Kim C Worley)</author>
      <author>hbellen@bcm.edu (Lauren S Blieden)</author>
      <author>hbellen@bcm.edu (Lindsay C Burrage)</author>
      <author>hbellen@bcm.edu (Mengqi Ma)</author>
      <author>hbellen@bcm.edu (Michael F Wangler)</author>
      <author>hbellen@bcm.edu (Michelle Etoundi)</author>
      <author>hbellen@bcm.edu (Mingxi Deng)</author>
      <author>hbellen@bcm.edu (Paolo Prontera)</author>
      <author>hbellen@bcm.edu (Pierre Blanc)</author>
      <author>hbellen@bcm.edu (Sandrine Marlin)</author>
      <author>hbellen@bcm.edu (Seema R Lalani)</author>
      <author>hbellen@bcm.edu (Shenzhao Lu)</author>
      <author>hbellen@bcm.edu (Shinya Yamamoto)</author>
      <author>hbellen@bcm.edu (Wei-Liang Chen)</author>
      <author>hbellen@bcm.edu (Xi Luo)</author>
      <author>hbellen@bcm.edu (Xueyang Pan)</author>
      <author>hbellen@bcm.edu (Yiming Zheng)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.95887</guid>
      <category>Genetics and Genomics</category>
      <category>Medicine</category>
      <pubDate>Wed, 27 Aug 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-08-27T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>A pair of congenic mice for imaging of transplants by positron emission tomography using anti-transferrin receptor nanobodies</title>
      <link>https://elifesciences.org/articles/104302</link>
      <description>Two anti-transferrin receptor (TfR) nanobodies, V&lt;sub&gt;H&lt;/sub&gt;H123 specific for mouse TfR and V&lt;sub&gt;H&lt;/sub&gt;H188 specific for human TfR, were used to track transplants non-invasively by PET/CT in mouse models, without the need for genetic modification of the transferred cells. We provide a comparison of the specificity and kinetics of the PET signals acquired when using nanobodies radiolabeled with &lt;sup&gt;89&lt;/sup&gt;Zr, &lt;sup&gt;64&lt;/sup&gt;Cu, and &lt;sup&gt;18&lt;/sup&gt;F, and find that the chelation of the &lt;sup&gt;89&lt;/sup&gt;Zr and &lt;sup&gt;64&lt;/sup&gt;Cu radioisotopes to anti-TfR nanobodies results in radioisotope release upon endocytosis of the radiolabeled nanobodies. We used a knock-in mouse that expresses a TfR with a human ectodomain (Tfrc&lt;i&gt;&lt;sup&gt;hu/hu&lt;/sup&gt;&lt;/i&gt;) as a source of bone marrow for transplants into C57BL/6 recipients and show that V&lt;sub&gt;H&lt;/sub&gt;H188 detects such transplants by PET/CT. Conversely, C57BL/6 bone marrow and B16.F10 melanoma cell line transplanted into Tfrc&lt;i&gt;&lt;sup&gt;hu/hu&lt;/sup&gt;&lt;/i&gt; recipients can be imaged with V&lt;sub&gt;H&lt;/sub&gt;H123. In C57BL/6 mice impregnated by Tfrc&lt;i&gt;&lt;sup&gt;hu/hu&lt;/sup&gt;&lt;/i&gt; males, we saw an intense V&lt;sub&gt;H&lt;/sub&gt;H188 signal in the placenta, showing that TfR-specific V&lt;sub&gt;H&lt;/sub&gt;Hs accumulate at the placental barrier but do not enter the fetal tissue. We were unable to observe accumulation of the anti-TfR radiotracers in the central nervous system (CNS) by PET/CT but showed evidence of CNS accumulation by radiospectrometry. The model presented here can be used to track many transplanted cell types by PET/CT, provided cells express TfR, as is typically the case for proliferating cells such as tumor lines.</description>
      <author>thomas.balligand@unamur.be (Bart De Strooper)</author>
      <author>thomas.balligand@unamur.be (Claire Carpenet)</author>
      <author>thomas.balligand@unamur.be (Hidde L Ploegh)</author>
      <author>thomas.balligand@unamur.be (Himadri Medhi)</author>
      <author>thomas.balligand@unamur.be (Maarten Dewilde)</author>
      <author>thomas.balligand@unamur.be (Mohammad Rashidian)</author>
      <author>thomas.balligand@unamur.be (Pavana Suresh)</author>
      <author>thomas.balligand@unamur.be (Sergi Olivé Palau)</author>
      <author>thomas.balligand@unamur.be (Thomas Balligand)</author>
      <author>thomas.balligand@unamur.be (Tom Jaspers)</author>
      <author>thomas.balligand@unamur.be (Xin Liu)</author>
      <author>thomas.balligand@unamur.be (Yoon Ho Lee)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104302</guid>
      <category>Immunology and Inflammation</category>
      <category>Medicine</category>
      <pubDate>Mon, 18 Aug 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-08-18T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Early menarche and childbirth accelerate aging-related outcomes and age-related diseases: Evidence for antagonistic pleiotropy in humans</title>
      <link>https://elifesciences.org/articles/102447</link>
      <author>pkapahi@buckinstitute.org (Lizellen La Follette)</author>
      <author>pkapahi@buckinstitute.org (Pankaj Kapahi)</author>
      <author>pkapahi@buckinstitute.org (Parminder Singh)</author>
      <author>pkapahi@buckinstitute.org (Vikram Pratap Narayan)</author>
      <author>pkapahi@buckinstitute.org (Vineeta Tanwar)</author>
      <author>pkapahi@buckinstitute.org (Yifan Xiang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.102447</guid>
      <category>Medicine</category>
      <pubDate>Tue, 12 Aug 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-08-12T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Acute aerobic exercise intensity does not modulate pain potentially due to differences in fitness levels and sex effects: results from a pharmacological fMRI study</title>
      <link>https://elifesciences.org/articles/102392</link>
      <description>Exercise might lead to a release of endogenous opioids, potentially resulting in pain relief. However, the neurobiological underpinnings of this effect remain unclear. Using a pharmacological within-subject functional magnetic resonance imaging (fMRI) study with the opioid antagonist naloxone and different levels of aerobic exercise and pain, we investigated exercise-induced hypoalgesia (&lt;i&gt;N&lt;/i&gt; = 39, 21 female). Overall, high-intensity (HI) aerobic exercise did not reduce pain as compared to low-intensity aerobic exercise. Accordingly, we observed no significant changes in the descending pain modulatory system. The µ-opioid antagonist naloxone significantly increased overall pain ratings but showed no interaction with exercise intensity. An exploratory analysis suggested an influence of fitness level (as indicated by the functional threshold power) and sex, where males showed greater hypoalgesia after HI exercise with increasing fitness levels. This effect was attenuated by naloxone and mirrored by fMRI signal changes in the medial frontal cortex, where activation also varied with fitness level and sex, and was reversed by naloxone. These results indicate that different aerobic exercise intensities have no differential effect on pain in a mixed population sample, but individual factors such as fitness level and sex might play a role. The current study underscores the need for personalised exercise interventions to enhance pain relief in healthy as well as chronic pain populations, taking into account the sex and fitness status as well as the necessity to further investigate the opioidergic involvement in exercise-induced pain modulation.</description>
      <author>j.nold@uke.de (Christian Büchel)</author>
      <author>j.nold@uke.de (Janne Ina Nold)</author>
      <author>j.nold@uke.de (Tahmine Fadai)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.102392</guid>
      <category>Medicine</category>
      <category>Neuroscience</category>
      <pubDate>Wed, 06 Aug 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-08-06T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Correction: Increase of cell surface vimentin is associated with vimentin network disruption and subsequent stress-induced premature senescence in human chondrocytes</title>
      <link>https://elifesciences.org/articles/108668</link>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.108668</guid>
      <category>Cell Biology</category>
      <category>Medicine</category>
      <pubDate>Thu, 31 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-31T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pilot study</title>
      <link>https://elifesciences.org/articles/101583</link>
      <author>everbright99@163.com (Ailin Li)</author>
      <author>everbright99@163.com (Caigang Liu)</author>
      <author>everbright99@163.com (Chao Liu)</author>
      <author>everbright99@163.com (Guanglei Chen)</author>
      <author>everbright99@163.com (Huilian Shan)</author>
      <author>everbright99@163.com (Jianfei Wang)</author>
      <author>everbright99@163.com (Jianqiao Yin)</author>
      <author>everbright99@163.com (Jinqi Xue)</author>
      <author>everbright99@163.com (Lisha Sun)</author>
      <author>everbright99@163.com (Meiyue Tang)</author>
      <author>everbright99@163.com (Mingxuan Jia)</author>
      <author>everbright99@163.com (Nan Niu)</author>
      <author>everbright99@163.com (Qianshi Xu)</author>
      <author>everbright99@163.com (Qingfu Zhang)</author>
      <author>everbright99@163.com (Shuo Cao)</author>
      <author>everbright99@163.com (Xiaofan Jiang)</author>
      <author>everbright99@163.com (Xu Zhang)</author>
      <author>everbright99@163.com (Yongliang Yang)</author>
      <author>everbright99@163.com (Yongqing Xu)</author>
      <author>everbright99@163.com (Yu Zhang)</author>
      <author>everbright99@163.com (Zhenyong Zhang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.101583</guid>
      <category>Medicine</category>
      <pubDate>Mon, 28 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-28T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Therapeutic effects of PDGF-AB/BB against cellular senescence in human intervertebral disc</title>
      <link>https://elifesciences.org/articles/103073</link>
      <description>Accumulation of senescent cells is closely linked with intervertebral disc (IVD) degeneration, a prevalent age-dependent chronic disorder causing low back pain. While previous studies have highlighted that platelet-derived growth factor (PDGF) mitigated IVD degeneration through anti-apoptotic and pro-anabolic effects, its impact on IVD cell senescence remains elusive. In this study, human NP and AF cells derived from aged, degenerated IVDs were treated with recombinant human (rh) PDGF-AB/BB for 5 d. Transcriptome profiling by mRNA sequencing revealed that NP and AF cells responded to the treatment in similar yet distinct ways. The effects of PDGF-AB and BB on human IVD cells were comparable. Specifically, rhPDGF-AB/BB treatment downregulated genes related to neurogenesis and mechanical stimulus response in AF cells, while in NP cells, metabolic pathways were predominantly suppressed. In both NP and AF cells, rhPDGF-AB/BB treatment upregulated genes involved in cell cycle regulation and response to reduced oxygen levels, while downregulating genes related to senescence-associated phenotype, including oxidative stress, reactive oxygen species (ROS), and mitochondria dysfunction. Network analysis revealed that PDGFRA and IL6 were the top hub genes in treated NP cells. Furthermore, in irradiation-induced senescent NP cells, PDGFRA gene expression was significantly reduced compared to non-irradiated cells. However, rhPDGF-AB/BB treatment increased PDGFRA expression and mitigated the senescence progression through increased cell population in the S phase, reduced SA-β-Gal activity, and decreased expression of senescence-related regulators. Our findings reveal a novel anti-senescence role of PDGF in the IVD, making it a promising potential candidate to delay aging-induced IVD degeneration.</description>
      <author>hicham.drissi@emory.edu (Changli Zhang)</author>
      <author>hicham.drissi@emory.edu (Hicham Drissi)</author>
      <author>hicham.drissi@emory.edu (Lisbet Haglund)</author>
      <author>hicham.drissi@emory.edu (Martha Elena Diaz-Hernandez)</author>
      <author>hicham.drissi@emory.edu (Sangwook Tim Yoon)</author>
      <author>hicham.drissi@emory.edu (Sreekala Shenoy)</author>
      <author>hicham.drissi@emory.edu (Takanori Fukunaga)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.103073</guid>
      <category>Medicine</category>
      <pubDate>Wed, 16 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-16T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>EPHA4 signaling dysregulation links abnormal locomotion and the development of idiopathic scoliosis</title>
      <link>https://elifesciences.org/articles/95324</link>
      <description>Idiopathic scoliosis (IS) is the most common form of spinal deformity with unclear pathogenesis. In this study, we first reanalyzed the loci associated with IS, drawing upon previous studies. Subsequently, we mapped these loci to candidate genes using either location-based or function-based strategies. To further substantiate our findings, we verified the enrichment of variants within these candidate genes across several large IS cohorts encompassing Chinese, East Asian, and European populations. Consequently, we identified variants in the &lt;i&gt;EPHA4&lt;/i&gt; gene as compelling candidates for IS. To confirm their pathogenicity, we generated zebrafish mutants of &lt;i&gt;epha4a&lt;/i&gt;. Remarkably, the zebrafish &lt;i&gt;epha4a&lt;/i&gt; mutants exhibited pronounced scoliosis during later stages of development, effectively recapitulating the IS phenotype. We observed that the &lt;i&gt;epha4a&lt;/i&gt; mutants displayed defects in left-right coordination during locomotion, which arose from disorganized neural activation in these mutants. Our subsequent experiments indicated that the disruption of the central pattern generator (CPG) network, characterized by abnormal axon guidance of spinal cord interneurons, contributed to the disorganization observed in the mutants. Moreover, when knocked down &lt;i&gt;efnb3b&lt;/i&gt;, the ligand for Epha4a, we observed similar CPG defects and disrupted left-right locomotion. These findings suggested that ephrin B3-Epha4 signaling is vital for the proper functioning of CPGs, and defects in this pathway could lead to scoliosis in zebrafish. Furthermore, we identified two cases of IS in &lt;i&gt;NGEF&lt;/i&gt;, a downstream molecule in the EPHA4 pathway. Collectively, our data provide compelling evidence that neural patterning impairments and disruptions in CPGs may underlie the pathogenesis of IS.</description>
      <author>jgzhang_pumch@yahoo.com (Anas M Khanshour)</author>
      <author>jgzhang_pumch@yahoo.com (Carol A Wise)</author>
      <author>jgzhang_pumch@yahoo.com (Chengtian Zhao)</author>
      <author>jgzhang_pumch@yahoo.com (Chikashi Terao)</author>
      <author>jgzhang_pumch@yahoo.com (Guixing Qiu)</author>
      <author>jgzhang_pumch@yahoo.com (Haibo Xie)</author>
      <author>jgzhang_pumch@yahoo.com (James R Lupski)</author>
      <author>jgzhang_pumch@yahoo.com (Jennifer E Posey)</author>
      <author>jgzhang_pumch@yahoo.com (Jianguo T Zhang)</author>
      <author>jgzhang_pumch@yahoo.com (Jonathan J Rios)</author>
      <author>jgzhang_pumch@yahoo.com (Junjun Liu)</author>
      <author>jgzhang_pumch@yahoo.com (Kexin Xu)</author>
      <author>jgzhang_pumch@yahoo.com (Lianlei Wang)</author>
      <author>jgzhang_pumch@yahoo.com (Lulu Li)</author>
      <author>jgzhang_pumch@yahoo.com (Nan Wu)</author>
      <author>jgzhang_pumch@yahoo.com (Nao Otomo)</author>
      <author>jgzhang_pumch@yahoo.com (Panpan Zhu)</author>
      <author>jgzhang_pumch@yahoo.com (Pengfei Liu)</author>
      <author>jgzhang_pumch@yahoo.com (Pengfei Zheng)</author>
      <author>jgzhang_pumch@yahoo.com (Qing Li)</author>
      <author>jgzhang_pumch@yahoo.com (Sen Liu)</author>
      <author>jgzhang_pumch@yahoo.com (Sen Zhao)</author>
      <author>jgzhang_pumch@yahoo.com (Shaoke Chen)</author>
      <author>jgzhang_pumch@yahoo.com (Shengru Wang)</author>
      <author>jgzhang_pumch@yahoo.com (Shiro Ikegawa)</author>
      <author>jgzhang_pumch@yahoo.com (Suomao Yuan)</author>
      <author>jgzhang_pumch@yahoo.com (Wen Wen)</author>
      <author>jgzhang_pumch@yahoo.com (Xiaoxin Li)</author>
      <author>jgzhang_pumch@yahoo.com (Xi Cheng)</author>
      <author>jgzhang_pumch@yahoo.com (Xin Fan)</author>
      <author>jgzhang_pumch@yahoo.com (Xinyu Yang)</author>
      <author>jgzhang_pumch@yahoo.com (Xiuli Zhao)</author>
      <author>jgzhang_pumch@yahoo.com (Yaqi Li)</author>
      <author>jgzhang_pumch@yahoo.com (Yoshinao Koike)</author>
      <author>jgzhang_pumch@yahoo.com (Yuchen Niu)</author>
      <author>jgzhang_pumch@yahoo.com (Zefu Chen)</author>
      <author>jgzhang_pumch@yahoo.com (Zhihong Wu)</author>
      <author>jgzhang_pumch@yahoo.com (Ziquan Li)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.95324</guid>
      <category>Genetics and Genomics</category>
      <category>Medicine</category>
      <pubDate>Tue, 15 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-15T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma</title>
      <link>https://elifesciences.org/articles/103256</link>
      <description>Trabecular meshwork (TM) cell therapy has been proposed as a next-generation treatment for elevated intraocular pressure (IOP) in glaucoma, the most common cause of irreversible blindness. Using a magnetic cell steering technique with excellent efficiency and tissue-specific targeting, we delivered two types of cells into a mouse model of glaucoma: either human adipose-derived mesenchymal stem cells (hAMSCs) or induced pluripotent cell derivatives (iPSC-TM cells). We observed a 4.5 [3.1, 6.0] mmHg or 27% reduction in intraocular pressure (IOP) for 9 months after a single dose of only 1500 magnetically steered hAMSCs, explained by increased outflow through the conventional pathway and associated with a higher TM cellularity. iPSC-TM cells were also effective, but less so, showing only a 1.9 [0.4, 3.3] mmHg or 13% IOP reduction and increased risk of tumorigenicity. In both cases, injected cells remained detectable in the iridocorneal angle 3 weeks post-transplantation. Based on the locations of the delivered cells, the mechanism of IOP lowering is most likely paracrine signaling. We conclude that magnetically steered hAMSC cell therapy has potential for long-term treatment of ocular hypertension in glaucoma.</description>
      <author>ross.ethier@bme.gatech.edu (Anamik Jhunjhunwala)</author>
      <author>ross.ethier@bme.gatech.edu (A Thomas Read)</author>
      <author>ross.ethier@bme.gatech.edu (Babak N Safa)</author>
      <author>ross.ethier@bme.gatech.edu (C Ross Ethier)</author>
      <author>ross.ethier@bme.gatech.edu (Guorong Li)</author>
      <author>ross.ethier@bme.gatech.edu (Hans E Grossniklaus)</author>
      <author>ross.ethier@bme.gatech.edu (Jessica Chan)</author>
      <author>ross.ethier@bme.gatech.edu (Lin Cheng)</author>
      <author>ross.ethier@bme.gatech.edu (Markus H Kuehn)</author>
      <author>ross.ethier@bme.gatech.edu (M Reza Bahranifard)</author>
      <author>ross.ethier@bme.gatech.edu (Seyed Mohammad Siadat)</author>
      <author>ross.ethier@bme.gatech.edu (Stanislav Y Emelianov)</author>
      <author>ross.ethier@bme.gatech.edu (W Daniel Stamer)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.103256</guid>
      <category>Medicine</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Mon, 07 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-07T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>The ESCRT protein CHMP5 restricts bone formation by controlling endolysosome-mitochondrion-mediated cell senescence</title>
      <link>https://elifesciences.org/articles/101984</link>
      <description>The dysfunction of the cellular endolysosomal pathway, such as in lysosomal storage diseases, can cause severe musculoskeletal disorders. However, how endolysosomal dysfunction causes musculoskeletal abnormalities remains poorly understood, limiting therapeutic options. Here, we report that CHMP5, a member of the endosomal sorting complex required for transport (ESCRT)-III protein family, is essential to maintain the endolysosomal pathway and regulate bone formation in osteogenic lineage cells. Genetic ablation of &lt;i&gt;Chmp5&lt;/i&gt; in mouse osteogenic cells increases bone formation in vivo and in vitro. Mechanistically, &lt;i&gt;Chmp5&lt;/i&gt; deletion causes endolysosomal dysfunction by decreasing the VPS4A protein, and CHMP5 overexpression is sufficient to increase the VPS4A protein. Subsequently, endolysosomal dysfunction disturbs mitochondrial functions and increases mitochondrial ROS, ultimately resulting in skeletal cell senescence. Senescent skeletal cells cause abnormal bone formation by combining cell-autonomous and paracrine actions. Importantly, the elimination of senescent cells using senolytic drugs can alleviate musculoskeletal abnormalities in &lt;i&gt;Chmp5&lt;/i&gt; conditional knockout mice. Therefore, our results show that cell senescence represents an underpinning mechanism and a therapeutic target for musculoskeletal disorders caused by the aberrant endolysosomal pathway, such as in lysosomal storage diseases. These results also uncover the function and mechanism of CHMP5 in the regulation of cell senescence by affecting the endolysosomal-mitochondrial pathway.</description>
      <author>jaehyuck.shim@umassmed.edu (Chunjie Wang)</author>
      <author>jaehyuck.shim@umassmed.edu (Cole M Haynes)</author>
      <author>jaehyuck.shim@umassmed.edu (Deping Chen)</author>
      <author>jaehyuck.shim@umassmed.edu (Fan Zhang)</author>
      <author>jaehyuck.shim@umassmed.edu (Haibo Liu)</author>
      <author>jaehyuck.shim@umassmed.edu (Jae-Hyuck Shim)</author>
      <author>jaehyuck.shim@umassmed.edu (Luyang Zhang)</author>
      <author>jaehyuck.shim@umassmed.edu (Ren Xu)</author>
      <author>jaehyuck.shim@umassmed.edu (Xianpeng Ge)</author>
      <author>jaehyuck.shim@umassmed.edu (Yuan Wang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.101984</guid>
      <category>Cell Biology</category>
      <category>Medicine</category>
      <pubDate>Mon, 07 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-07T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice</title>
      <link>https://elifesciences.org/articles/101830</link>
      <description>Chronic inflammation via dysregulation of T cell immune responses is critically involved in the pathogenesis of atherosclerotic cardiovascular disease. Improving the balance between proinflammatory T cells and anti-inflammatory regulatory T cells (Tregs) may be an attractive approach for treating atherosclerosis. Although C-C chemokine receptor 4 (CCR4) has been shown to mediate the recruitment of T cells to inflamed tissues, its role in atherosclerosis is unclear. Here, we show that genetic deletion of CCR4 in hypercholesterolemic mice accelerates the development of early atherosclerotic lesions characterized by an inflammatory plaque phenotype. This was associated with the augmentation of proinflammatory T helper type 1 (Th1) cell responses in peripheral lymphoid tissues, para-aortic lymph nodes, and atherosclerotic aorta. Mechanistically, CCR4 deficiency in Tregs impaired their suppressive function and tended to inhibit their migration to the atherosclerotic aorta, and subsequently augmented Th1 cell-mediated immune responses through defective regulation of dendritic cell function, which accelerated aortic inflammation and atherosclerotic lesion development. Thus, we revealed a previously unrecognized role for CCR4 in controlling the early stage of atherosclerosis via Treg-dependent regulation of proinflammatory T cell responses. Our data suggest that CCR4 is an important negative regulator of atherosclerosis.</description>
      <author>n-sasaki@kobepharma-u.ac.jp (Aga Krisnanda)</author>
      <author>n-sasaki@kobepharma-u.ac.jp (Hilman Zulkifli Amin)</author>
      <author>n-sasaki@kobepharma-u.ac.jp (Kazuhiko Matsuo)</author>
      <author>n-sasaki@kobepharma-u.ac.jp (Ken-ichi Hirata)</author>
      <author>n-sasaki@kobepharma-u.ac.jp (Ken Ito)</author>
      <author>n-sasaki@kobepharma-u.ac.jp (Naoto Sasaki)</author>
      <author>n-sasaki@kobepharma-u.ac.jp (Sayo Horibe)</author>
      <author>n-sasaki@kobepharma-u.ac.jp (Takashi Nakayama)</author>
      <author>n-sasaki@kobepharma-u.ac.jp (Toru Tanaka)</author>
      <author>n-sasaki@kobepharma-u.ac.jp (Yoshiyuki Rikitake)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.101830</guid>
      <category>Immunology and Inflammation</category>
      <category>Medicine</category>
      <pubDate>Thu, 03 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-03T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis</title>
      <link>https://elifesciences.org/articles/103559</link>
      <author>wangliang@jnu.edu.cn (Hanyang Guan)</author>
      <author>wangliang@jnu.edu.cn (Haoquan Li)</author>
      <author>wangliang@jnu.edu.cn (Hui Ding)</author>
      <author>wangliang@jnu.edu.cn (Jiashuai He)</author>
      <author>wangliang@jnu.edu.cn (Jinghua Pan)</author>
      <author>wangliang@jnu.edu.cn (Liang Wang)</author>
      <author>wangliang@jnu.edu.cn (Shenghui Qiu)</author>
      <author>wangliang@jnu.edu.cn (Shijin Liu)</author>
      <author>wangliang@jnu.edu.cn (Tianmu Mo)</author>
      <author>wangliang@jnu.edu.cn (Xiangwei Zhang)</author>
      <author>wangliang@jnu.edu.cn (Xiaoxu Zhao)</author>
      <author>wangliang@jnu.edu.cn (Yiran Zhang)</author>
      <author>wangliang@jnu.edu.cn (Yunlong Pan)</author>
      <author>wangliang@jnu.edu.cn (Zhan Zhao)</author>
      <author>wangliang@jnu.edu.cn (Zili Bian)</author>
      <author>wangliang@jnu.edu.cn (Zuyang Chen)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.103559</guid>
      <category>Cancer Biology</category>
      <category>Medicine</category>
      <pubDate>Thu, 26 Jun 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-06-26T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Multiple roles for a mitochondrial enzyme</title>
      <link>https://elifesciences.org/articles/107882</link>
      <description>The enzyme arginase-II has an important role in cardiac aging, and blocking it could help hearts stay young longer.</description>
      <author>hqiu@arizona.edu (Hongyu Qiu)</author>
      <author>hqiu@arizona.edu (Xicong Tang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107882</guid>
      <category>Medicine</category>
      <pubDate>Mon, 16 Jun 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-06-16T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
  </channel>
</rss>
